Clinical Trials Browser

Phase 1 × Recurrence × tisagenlecleucel × Clear all

NCT03876028 2023-01-31

Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma Patients

Phase 1 Terminated

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse